Endo Expands ADRENALIN® Portfolio With New FDA-Approved Premixed IV Bags
MALVERN, PA — Endo, a subsidiary of Mallinckrodt plc, has expanded its ADRENALIN® line with the launch of three new FDA-approved premixed intravenous (IV) bag concentrations: 2 mg/250 mL, 5 …
Endo Expands ADRENALIN® Portfolio With New FDA-Approved Premixed IV Bags Read More